Likelike personal page - To The Moon

Likelike

Likelike

Like like

115Follow

30Followers

0Topic

0Badge

09-16

$Wolfspeed Inc.(WOLF)$

09-08

$Richtech Robotics(RR)$

09-08

$Richtech Robotics(RR)$

09-06

09-06

08-16

08-10

08-02

06-11

$SoFi Technologies Inc.(SOFI)$ finally

06-11

$SoFi Technologies Inc.(SOFI)$ finally over

06-08

$SoFi Technologies Inc.(SOFI)$ hard earn

2024-10-28

2024-10-21

2023-02-02

thanks 😊

2021-09-23

Nio niu (bull)ah!

Nio Said To Delay Unveiling Of ES8, Nio House In Norway By A Week

2021-09-23

Pfizer can reach $50 by Oct....i wish

Despite Vaccine Uncertainty, Pfizer Is a Buy

2021-09-22

Maybe Apple can consider learn from Xiaomi,sell Smart systems on almost everything from robot vaccum to humidifier haha....

Sorry, the original content has been removed

2021-09-14

ford should be a $15 share..i wish

Ford Motor Says Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer

2021-09-14

sold first maybe buy later <8,pls like n share your comments thanks

Ocugen shares surged more than 13% in Monday morning trading

2021-09-12

$19X by end year

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4091708143350050","uuid":"4091708143350050","gmtCreate":1628605862019,"gmtModify":1632926032280,"name":"Likelike","pinyin":"likelike","introduction":"","introductionEn":null,"signature":"Like like","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":30,"headSize":115,"tweetSize":56,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.24","exceedPercentage":"80.67%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":18,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":478955051847808,"gmtCreate":1757952947014,"gmtModify":1757952949668,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/WOLF\">$Wolfspeed Inc.(WOLF)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/WOLF\">$Wolfspeed Inc.(WOLF)$ </a>&nbsp;","text":"$Wolfspeed Inc.(WOLF)$","images":[{"img":"https://community-static.tradeup.com/news/12c7f94429a29c34af6391e344f8b971","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/478955051847808","isVote":1,"tweetType":1,"viewCount":653,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":476427144097840,"gmtCreate":1757342657708,"gmtModify":1757342660164,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/RR\">$Richtech Robotics(RR)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/RR\">$Richtech Robotics(RR)$ </a>&nbsp;","text":"$Richtech Robotics(RR)$","images":[{"img":"https://community-static.tradeup.com/news/e4fb848651453b15e64456e8e203f06e","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/476427144097840","isVote":1,"tweetType":1,"viewCount":610,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":476427118252368,"gmtCreate":1757342619882,"gmtModify":1757342623432,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/RR\">$Richtech Robotics(RR)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/RR\">$Richtech Robotics(RR)$ </a>&nbsp;","text":"$Richtech Robotics(RR)$","images":[{"img":"https://community-static.tradeup.com/news/e085bae5033c62bb0e9b3b015c870900","width":"1080","height":"2748"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/476427118252368","isVote":1,"tweetType":1,"viewCount":747,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":475725486551304,"gmtCreate":1757171321922,"gmtModify":1757171323446,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","text":"$NVIDIA(NVDA)$","images":[{"img":"https://community-static.tradeup.com/news/faa5660385d84fd16372b402d61264fb","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/475725486551304","isVote":1,"tweetType":1,"viewCount":528,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":475725429145960,"gmtCreate":1757171198818,"gmtModify":1757171204976,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","text":"$NVIDIA(NVDA)$","images":[{"img":"https://community-static.tradeup.com/news/eaa06eeeab6aa14d0c826e1d82eac699","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/475725429145960","isVote":1,"tweetType":1,"viewCount":503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":468266240549080,"gmtCreate":1755347562860,"gmtModify":1755347565870,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","text":"$NVIDIA(NVDA)$","images":[{"img":"https://community-static.tradeup.com/news/46fcbcaa2a0d9930fb53d9a14b2d63e1","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/468266240549080","isVote":1,"tweetType":1,"viewCount":743,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":466125465383336,"gmtCreate":1754809933476,"gmtModify":1754809940601,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","text":"$NVIDIA(NVDA)$","images":[{"img":"https://community-static.tradeup.com/news/cdba361f27e73e93da110cef828a4bdb","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/466125465383336","isVote":1,"tweetType":1,"viewCount":659,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":463009151791664,"gmtCreate":1754069060948,"gmtModify":1754069065102,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","text":"$NVIDIA(NVDA)$","images":[{"img":"https://community-static.tradeup.com/news/991484a3181250a4f31ade70f4eee092","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/463009151791664","isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":444926642680448,"gmtCreate":1749648958485,"gmtModify":1749648962561,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SOFI\">$SoFi Technologies Inc.(SOFI)$ </a> finally","listText":"<a href=\"https://ttm.financial/S/SOFI\">$SoFi Technologies Inc.(SOFI)$ </a> finally","text":"$SoFi Technologies Inc.(SOFI)$ finally","images":[{"img":"https://community-static.tradeup.com/news/7ae5b9d69ad885ff549d36307b88edc5","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/444926642680448","isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":444926632477088,"gmtCreate":1749648867590,"gmtModify":1749648871497,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SOFI\">$SoFi Technologies Inc.(SOFI)$ </a> finally over","listText":"<a href=\"https://ttm.financial/S/SOFI\">$SoFi Technologies Inc.(SOFI)$ </a> finally over","text":"$SoFi Technologies Inc.(SOFI)$ finally over","images":[{"img":"https://community-static.tradeup.com/news/c501dc33f6293bf4da70e39fead47cb7","width":"1080","height":"2834"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/444926632477088","isVote":1,"tweetType":1,"viewCount":1112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":443584920121824,"gmtCreate":1749319677111,"gmtModify":1749319681003,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SOFI\">$SoFi Technologies Inc.(SOFI)$ </a> hard earn","listText":"<a href=\"https://ttm.financial/S/SOFI\">$SoFi Technologies Inc.(SOFI)$ </a> hard earn","text":"$SoFi Technologies Inc.(SOFI)$ hard earn","images":[{"img":"https://community-static.tradeup.com/news/0000051583073749b0dc7c24f4f1981e","width":"1080","height":"2908"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/443584920121824","isVote":1,"tweetType":1,"viewCount":1229,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":364998089552032,"gmtCreate":1730121102013,"gmtModify":1730121106849,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$ </a>&nbsp;","text":"$Apple(AAPL)$","images":[{"img":"https://community-static.tradeup.com/news/97f1fb631fa117474fa95250eb4e31cd","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/364998089552032","isVote":1,"tweetType":1,"viewCount":2319,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"10000000000010968","authorId":"10000000000010968","name":"Tiger_CashBoostAccount","avatar":"https://community-static.tradeup.com/news/ae2d4002ef9664aba005cb3020f416f5","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"10000000000010968","idStr":"10000000000010968"},"content":"Great job on your latest stock market success! Your commitment to research and analysis is evident in your results. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.🥳💹💰🤩 Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.","text":"Great job on your latest stock market success! Your commitment to research and analysis is evident in your results. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.🥳💹💰🤩 Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.","html":"Great job on your latest stock market success! Your commitment to research and analysis is evident in your results. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.🥳💹💰🤩 Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":362453877051392,"gmtCreate":1729525626876,"gmtModify":1729525631290,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$ </a>&nbsp;","text":"$Apple(AAPL)$","images":[{"img":"https://community-static.tradeup.com/news/f3b0375635ab832502e55203cfa6ae4b","width":"1080","height":"2379"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/362453877051392","isVote":1,"tweetType":1,"viewCount":2451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9955145856,"gmtCreate":1675301485576,"gmtModify":1676538990786,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;thanks&nbsp;😊&nbsp;","listText":"&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;thanks&nbsp;😊&nbsp;","text":"thanks 😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955145856","isVote":1,"tweetType":1,"viewCount":1884,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863228838,"gmtCreate":1632400543624,"gmtModify":1676530772779,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"Nio niu (bull)ah!","listText":"Nio niu (bull)ah!","text":"Nio niu (bull)ah!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/863228838","repostId":"1135139549","repostType":4,"repost":{"id":"1135139549","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1632386313,"share":"https://ttm.financial/m/news/1135139549?lang=&edition=fundamental","pubTime":"2021-09-23 16:38","market":"us","language":"en","title":"Nio Said To Delay Unveiling Of ES8, Nio House In Norway By A Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1135139549","media":"Benzinga","summary":"Chinese electric vehicle maker NIO Inc. is delaying the official launch of the ES8 SUV and the openi","content":"<p>Chinese electric vehicle maker&nbsp;<b><a href=\"https://laohu8.com/S/NIO\">NIO Inc.</a></b> is delaying the official launch of the ES8 SUV and the opening of the first overseas&nbsp;<b>Nio House</b>&nbsp;in Norway by a week, cnEVpostreportedWednesday.</p>\n<p><b>What Happened</b>: Nio will now launch the ES8 in Norway on Sept. 30 while the first local Nio House in Oslo will be officially open for business from Oct. 1, as per the report that&nbsp;<b>Marius Hayler</b>, general manager of Nio Norway.</p>\n<p>The report did not provide any details about the reasons for the delay. It was&nbsp;reported&nbsp;earlier this month the EV maker will open the Nio House in Norway and also announce the local pricing of its flagship ES8 model on Sept. 23.</p>\n<p>Nio House is the EV maker’s concept store.</p>\n<p><b>Why It Matters</b>: &nbsp;Nio’s entry into Norway marks the first step in an ambitious overseas expansion plan charted by the EV maker, which has found success in <a href=\"https://laohu8.com/S/CAAS\">China</a> as a seller of premium electric vehicles.</p>\n<p>NIO CEO<b>Wiliam Li</b>has said that the company may expand into Germany, followed by other European countries, if it achieves success in Norway.</p>\n<p><b>Price Action</b>: Nio shares closed almost 2.3% higher in Wednesday’s trading at $35.70.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nio Said To Delay Unveiling Of ES8, Nio House In Norway By A Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNio Said To Delay Unveiling Of ES8, Nio House In Norway By A Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-23 16:38</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Chinese electric vehicle maker&nbsp;<b><a href=\"https://laohu8.com/S/NIO\">NIO Inc.</a></b> is delaying the official launch of the ES8 SUV and the opening of the first overseas&nbsp;<b>Nio House</b>&nbsp;in Norway by a week, cnEVpostreportedWednesday.</p>\n<p><b>What Happened</b>: Nio will now launch the ES8 in Norway on Sept. 30 while the first local Nio House in Oslo will be officially open for business from Oct. 1, as per the report that&nbsp;<b>Marius Hayler</b>, general manager of Nio Norway.</p>\n<p>The report did not provide any details about the reasons for the delay. It was&nbsp;reported&nbsp;earlier this month the EV maker will open the Nio House in Norway and also announce the local pricing of its flagship ES8 model on Sept. 23.</p>\n<p>Nio House is the EV maker’s concept store.</p>\n<p><b>Why It Matters</b>: &nbsp;Nio’s entry into Norway marks the first step in an ambitious overseas expansion plan charted by the EV maker, which has found success in <a href=\"https://laohu8.com/S/CAAS\">China</a> as a seller of premium electric vehicles.</p>\n<p>NIO CEO<b>Wiliam Li</b>has said that the company may expand into Germany, followed by other European countries, if it achieves success in Norway.</p>\n<p><b>Price Action</b>: Nio shares closed almost 2.3% higher in Wednesday’s trading at $35.70.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135139549","content_text":"Chinese electric vehicle maker NIO Inc. is delaying the official launch of the ES8 SUV and the opening of the first overseas Nio House in Norway by a week, cnEVpostreportedWednesday.\nWhat Happened: Nio will now launch the ES8 in Norway on Sept. 30 while the first local Nio House in Oslo will be officially open for business from Oct. 1, as per the report that Marius Hayler, general manager of Nio Norway.\nThe report did not provide any details about the reasons for the delay. It was reported earlier this month the EV maker will open the Nio House in Norway and also announce the local pricing of its flagship ES8 model on Sept. 23.\nNio House is the EV maker’s concept store.\nWhy It Matters:  Nio’s entry into Norway marks the first step in an ambitious overseas expansion plan charted by the EV maker, which has found success in China as a seller of premium electric vehicles.\nNIO CEOWiliam Lihas said that the company may expand into Germany, followed by other European countries, if it achieves success in Norway.\nPrice Action: Nio shares closed almost 2.3% higher in Wednesday’s trading at $35.70.","news_type":1,"symbols_score_info":{"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":2697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863229400,"gmtCreate":1632400374400,"gmtModify":1676530772716,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"Pfizer can reach $50 by Oct....i wish","listText":"Pfizer can reach $50 by Oct....i wish","text":"Pfizer can reach $50 by Oct....i wish","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/863229400","repostId":"1133566174","repostType":4,"repost":{"id":"1133566174","kind":"news","pubTimestamp":1632397453,"share":"https://ttm.financial/m/news/1133566174?lang=&edition=fundamental","pubTime":"2021-09-23 19:44","market":"us","language":"en","title":"Despite Vaccine Uncertainty, Pfizer Is a Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=1133566174","media":"InvestorPlace","summary":"Forget the booster shot controversy, PFE stock has better days ahead.\n\nWhat would happen if a compan","content":"<div>\n<p>Forget the booster shot controversy, PFE stock has better days ahead.\n\nWhat would happen if a company developed a massive new product and no one cared? For Pfizer’s investors, that has been the ...</p>\n\n<a href=\"https://investorplace.com/2021/09/despite-vaccine-uncertainty-pfizer-is-a-buy/\">Web Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Despite Vaccine Uncertainty, Pfizer Is a Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDespite Vaccine Uncertainty, Pfizer Is a Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 19:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/09/despite-vaccine-uncertainty-pfizer-is-a-buy/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Forget the booster shot controversy, PFE stock has better days ahead.\n\nWhat would happen if a company developed a massive new product and no one cared? For Pfizer’s investors, that has been the ...</p>\n\n<a href=\"https://investorplace.com/2021/09/despite-vaccine-uncertainty-pfizer-is-a-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://investorplace.com/2021/09/despite-vaccine-uncertainty-pfizer-is-a-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133566174","content_text":"Forget the booster shot controversy, PFE stock has better days ahead.\n\nWhat would happen if a company developed a massive new product and no one cared? For Pfizer’s investors, that has been the question for the past year. Despite coming up with a blockbuster vaccine for the novel coronavirus, PFE stock did basically nothing for an extended period.\nThat finally changed this summer, when Pfizer belatedly rallied to new all-time highs. Now though, the gains are fading almost as quickly as they happened. In its Q2 earnings release, Pfizer reported 93% year-over-year revenue growth. Yet shares are up less than 20% over the past 12 months. Why have investors not given Pfizer credit for its performance, and will that change in the future?\nVaccine Hits A Setback\nPfizer has enjoyed incredible revenue growth over the past year due to its Covid-19 vaccine. The majority of vaccinated American adults have taken the Pfizer vaccine, and it’s had strong sales overseas as well.\nDespite that, however, PFE stock didn’t move too much. At least, not until July of this year. At that time, PFE stock finally took off. The reason why is that investors started to price in the expectation that people would need to take vaccine booster shots to maintain efficacy.\nThe idea of a third, and potentially even fourth or more dose of vaccines would have created a far more enduring revenue boost for Pfizer. Up until recently, investors had shied away from Pfizer despite its massive top-line growth because they anticipated that the Covid business would quickly recede. With booster shots, however, the vaccine would have taken on another level of importance to the company.\nThis scenario is now under increasing doubt, however. A Food and Drug Administration (FDA) advisory panel recentlyrecommended againstadvising booster shots of the Pfizer vaccine. A large majority of the panelists voted that the data on hand was insufficient to warrant booster shots. That comes amid reports that Moderna’s(NASDAQ:MRNA) vaccine remains effective in a higher percentage of people than Pfizer’s after 120 days.\nThis is hardly the final word on booster shots or the efficacy of Moderna versus Pfizer. Pfizer’s investors shouldn’t discount the possibility that the FDA later comes around on additional rounds of the vaccine. For now, however, the prospects are looking more uncertain.\nBaseline Valuation Is Not That Demanding\nLet’s go back in time to 2019 and pretend that we’ve never heard of the pandemic. What does an investment in Pfizer look like in this hypothetical scenario? For full-year 2018, Pfizer generated $1.87 of EPS. In 2019, this leapt to $2.87.\nBased on today’s stock price just below $44, PFE stock is selling at 23x 2018 earnings or 15x 2019 earnings. With no benefit from the current Covid-19 vaccine whatsoever, Pfizer stock would still be going for a reasonable multiple.\nYes, you can argue that pharmaceutical companies should trade for lower P/E multiples than many other industries given the high cost of drug development and quick patent expiries. Still, with earnings as strong as they were in 2018-19, it’s not hard to get behind the stock at $44 even if you give the company zero credit for the Covid-19 vaccine. Forget about booster shots for a minute, traders are pricing Pfizer like there will be little more revenue from the vaccine whatsoever.\nPFE Stock Verdict\nRight now, Pfizer stock is inextricably linked to its vaccine’s outlook. When there is positive news on that front, PFE stock surges. When there is a setback, PFE stock sells off hard. That’s a totally understandable market reaction. Many traders are trained to react quickly to the latest headline.\nFor longer-term investors, however, Pfizer is an opportunity regardless of the trajectory of the vaccine. Even if boosters ultimately aren’t a big thing, Pfizer can still make investors money from this entry point.\nThe company is a tremendous diversified pharmaceutical giant. It was in good shape long before the pandemic, and it has dozens of promising drugs in its pipeline to power it for the next decade and beyond. The company is reaping a windfall right now, but it’s not like that’s its only iron in the fire.\nIf the Covid-19 business continues longer than forecast, that’s all upside to the stock price. However, from this starting point, there’s sufficient margin of safety to support a purchase in most possible outcomes.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2958,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4092216435500580","authorId":"4092216435500580","name":"SimonSim","avatar":"https://static.tigerbbs.com/f2870d5ab54ba75f2d74ad8cb044473a","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"4092216435500580","idStr":"4092216435500580"},"content":"[Happy] [Happy] [Happy]","text":"[Happy] [Happy] [Happy]","html":"[Happy] [Happy] [Happy]"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869784588,"gmtCreate":1632322282944,"gmtModify":1676530752993,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"Maybe&nbsp;Apple can consider learn from Xiaomi,sell Smart systems on almost everything from robot vaccum to humidifier haha....","listText":"Maybe&nbsp;Apple can consider learn from Xiaomi,sell Smart systems on almost everything from robot vaccum to humidifier haha....","text":"Maybe Apple can consider learn from Xiaomi,sell Smart systems on almost everything from robot vaccum to humidifier haha....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/869784588","repostId":"1143821004","repostType":4,"isVote":1,"tweetType":1,"viewCount":2498,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3580536610076415","authorId":"3580536610076415","name":"BettyT","avatar":"https://static.tigerbbs.com/6a4dfe2f455acd2af7629f83ce30e20c","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3580536610076415","idStr":"3580536610076415"},"content":"diversified ? Haha ??","text":"diversified ? Haha ??","html":"diversified ? Haha ??"},{"author":{"id":"3582064943200061","authorId":"3582064943200061","name":"EPK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3582064943200061","idStr":"3582064943200061"},"content":"Seems like only Xiaomi on thIs Strategy for now?","text":"Seems like only Xiaomi on thIs Strategy for now?","html":"Seems like only Xiaomi on thIs Strategy for now?"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886336965,"gmtCreate":1631549461457,"gmtModify":1676530574165,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"ford should be a $15 share..i wish","listText":"ford should be a $15 share..i wish","text":"ford should be a $15 share..i wish","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/886336965","repostId":"2167658404","repostType":2,"repost":{"id":"2167658404","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1631545694,"share":"https://ttm.financial/m/news/2167658404?lang=&edition=fundamental","pubTime":"2021-09-13 23:08","market":"us","language":"en","title":"Ford Motor Says Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2167658404","media":"T-Reuters","summary":"Ford Motor Co :Ford Motor Co - Mike Amend Starts With Ford Today As The New Chief Digital And Inform","content":"<html><body><p>Ford Motor Co <f.n>:Ford Motor Co - Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer.Further Company Coverage: F.N. ((Reuters.Briefs@Thomsonreuters.Com;)).</f.n></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford Motor Says Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord Motor Says Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-09-13 23:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Ford Motor Co <f.n>:Ford Motor Co - Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer.Further Company Coverage: F.N. ((Reuters.Briefs@Thomsonreuters.Com;)).</f.n></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"III":"信息服务","DLR":"数字房地产信托公司","F":"福特汽车","NGD":"New Gold"},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167658404","content_text":"Ford Motor Co :Ford Motor Co - Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer.Further Company Coverage: F.N. ((Reuters.Briefs@Thomsonreuters.Com;)).","news_type":1,"symbols_score_info":{"DLR":1,"NGD":1,"III":1,"F":1}},"isVote":1,"tweetType":1,"viewCount":2686,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3586655655659820","authorId":"3586655655659820","name":"sunshine138","avatar":"https://static.tigerbbs.com/23149c63a63bfeec1572cc27e1322750","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3586655655659820","idStr":"3586655655659820"},"content":"When will it move there","text":"When will it move there","html":"When will it move there"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886333560,"gmtCreate":1631549154550,"gmtModify":1676530574110,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"sold first maybe buy later &lt;8,pls like n share your comments&nbsp;thanks","listText":"sold first maybe buy later &lt;8,pls like n share your comments&nbsp;thanks","text":"sold first maybe buy later <8,pls like n share your comments thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/886333560","repostId":"1126978010","repostType":4,"repost":{"id":"1126978010","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631544701,"share":"https://ttm.financial/m/news/1126978010?lang=&edition=fundamental","pubTime":"2021-09-13 22:51","market":"us","language":"en","title":"Ocugen shares surged more than 13% in Monday morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1126978010","media":"Tiger Newspress","summary":"Ocugen shares surged more than 13% in Monday morning trading.\n\nVarious companies have been engaged i","content":"<p>Ocugen shares surged more than 13%&nbsp;in Monday morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/8fcba6c91ee88af0dd90608a79065282\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Various companies have been engaged in producing COVID-19 vaccines since the onset of the pandemic.</p>\n<p>Clinical-stage biotech firm Ocugen (<b>OCGN</b>) joined the race in December 2020, announcing its partnership with India-based Bharat Biotech. Ocugen collaborated with the Indian biotech company to jointly develop Covaxin.</p>\n<p>The announcement helped its stock to propel from under 30 cents a share to a stunning, eventual high of&nbsp;$18.77 a share in February. However, prices plummeted to nearly $9 per share in the next month.</p>\n<p>As rival companies came forward with their vaccines while Ocugen lagged behind, the stock started to bleed.</p>\n<p>However, OCGN stock is once again witnessing an upward move. Here’s a detailed analysis to find out what’s really happening with the stock. I’m neutral on Ocugen.</p>\n<p><b>Delta Variant Concerns Pushing OCGN Stock up</b></p>\n<p>Newly discovered variants of COVID-19 have been a major cause of concern lately. These variants are more infectious, and resistant, to the already existing COVID-19 vaccines. The Delta variant is one such dangerous strain that has caught the attention of people worldwide.</p>\n<p>This new variant has piqued global interest in Ocugen, and its Covaxin. Notably, Covaxin is yet to receive approval from FDA. However, the once-forgotten OCGN stock is again back in the discussion, with stock prices moving up by a decent 8.5% in August.</p>\n<p>According to many analysts, value investors aren’t interested in this stock. Rather, it is mainly retail investors who are eyeing Ocugen for some quick profit.</p>\n<p><b>Short-term Catalyst behind the Sudden Spike</b></p>\n<p>Ocugen has been jointly developing Covaxin with Bharat Biotech for use in the North American market. Share prices suffered a decline when Ocugen was denied emergency-use authorization from the FDA, which recommended that the company apply for a biologics-license application instead.</p>\n<p>Health Canada is reviewing Covaxin currently. It has not yet been granted approval. However, the news of review was enough to push Ocugen stock higher.</p>\n<p>Moreover, the company intends to submit an Investigational New Drug application for one of its gene therapy candidates. OCU400 is designed to target retinal diseases. Ocugen has already started to assess options to begin trials in Europe in 2022.</p>\n<p><b>Ocugen Needs to Progress</b></p>\n<p>The biotech company released a much-awaited business update on August 6. Ocugen failed to generate revenue during the second quarter. Unlike many of its rivals, it doesn’t have any commercialized products at the moment.</p>\n<p>On top of that, it posted a&nbsp;net loss of $26 million during Q2. Expenses related to research and development stood at $18.9 million in the current quarter, as opposed to $1.6 million last year. In addition, administrative expenses increased by 279.8% year-over-year, to $6.8 million.</p>\n<p>As of June 30, cash and cash equivalents stood at $115.6 million.</p>\n<p><b>Wall Street’s Take</b></p>\n<p>As per TipRanks’ analyst rating consensus, Ocugen stock is a Moderate Buy. Out of four analysts, there are two Buy recommendations, and two Hold recommendations.</p>\n<p>The&nbsp;average OCGN price target&nbsp;is $8.88. The analyst price targets range from a high of $15 per share, to a low of $4.50 per share.</p>\n<p><img src=\"https://static.tigerbbs.com/9c696ea686fdeaa8d6550e1282efebf7\" tg-width=\"1099\" tg-height=\"374\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Bottom Line</b></p>\n<p>Ocugen stock could very well profit from the mounting global concerns about the Delta variant.</p>\n<p>There might even be a stock rally. However, the company is badly in need of positive regulatory updates right now.</p>\n<p>It’s an interesting play, but not without risk.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen shares surged more than 13% in Monday morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen shares surged more than 13% in Monday morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-13 22:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen shares surged more than 13%&nbsp;in Monday morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/8fcba6c91ee88af0dd90608a79065282\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Various companies have been engaged in producing COVID-19 vaccines since the onset of the pandemic.</p>\n<p>Clinical-stage biotech firm Ocugen (<b>OCGN</b>) joined the race in December 2020, announcing its partnership with India-based Bharat Biotech. Ocugen collaborated with the Indian biotech company to jointly develop Covaxin.</p>\n<p>The announcement helped its stock to propel from under 30 cents a share to a stunning, eventual high of&nbsp;$18.77 a share in February. However, prices plummeted to nearly $9 per share in the next month.</p>\n<p>As rival companies came forward with their vaccines while Ocugen lagged behind, the stock started to bleed.</p>\n<p>However, OCGN stock is once again witnessing an upward move. Here’s a detailed analysis to find out what’s really happening with the stock. I’m neutral on Ocugen.</p>\n<p><b>Delta Variant Concerns Pushing OCGN Stock up</b></p>\n<p>Newly discovered variants of COVID-19 have been a major cause of concern lately. These variants are more infectious, and resistant, to the already existing COVID-19 vaccines. The Delta variant is one such dangerous strain that has caught the attention of people worldwide.</p>\n<p>This new variant has piqued global interest in Ocugen, and its Covaxin. Notably, Covaxin is yet to receive approval from FDA. However, the once-forgotten OCGN stock is again back in the discussion, with stock prices moving up by a decent 8.5% in August.</p>\n<p>According to many analysts, value investors aren’t interested in this stock. Rather, it is mainly retail investors who are eyeing Ocugen for some quick profit.</p>\n<p><b>Short-term Catalyst behind the Sudden Spike</b></p>\n<p>Ocugen has been jointly developing Covaxin with Bharat Biotech for use in the North American market. Share prices suffered a decline when Ocugen was denied emergency-use authorization from the FDA, which recommended that the company apply for a biologics-license application instead.</p>\n<p>Health Canada is reviewing Covaxin currently. It has not yet been granted approval. However, the news of review was enough to push Ocugen stock higher.</p>\n<p>Moreover, the company intends to submit an Investigational New Drug application for one of its gene therapy candidates. OCU400 is designed to target retinal diseases. Ocugen has already started to assess options to begin trials in Europe in 2022.</p>\n<p><b>Ocugen Needs to Progress</b></p>\n<p>The biotech company released a much-awaited business update on August 6. Ocugen failed to generate revenue during the second quarter. Unlike many of its rivals, it doesn’t have any commercialized products at the moment.</p>\n<p>On top of that, it posted a&nbsp;net loss of $26 million during Q2. Expenses related to research and development stood at $18.9 million in the current quarter, as opposed to $1.6 million last year. In addition, administrative expenses increased by 279.8% year-over-year, to $6.8 million.</p>\n<p>As of June 30, cash and cash equivalents stood at $115.6 million.</p>\n<p><b>Wall Street’s Take</b></p>\n<p>As per TipRanks’ analyst rating consensus, Ocugen stock is a Moderate Buy. Out of four analysts, there are two Buy recommendations, and two Hold recommendations.</p>\n<p>The&nbsp;average OCGN price target&nbsp;is $8.88. The analyst price targets range from a high of $15 per share, to a low of $4.50 per share.</p>\n<p><img src=\"https://static.tigerbbs.com/9c696ea686fdeaa8d6550e1282efebf7\" tg-width=\"1099\" tg-height=\"374\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Bottom Line</b></p>\n<p>Ocugen stock could very well profit from the mounting global concerns about the Delta variant.</p>\n<p>There might even be a stock rally. However, the company is badly in need of positive regulatory updates right now.</p>\n<p>It’s an interesting play, but not without risk.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126978010","content_text":"Ocugen shares surged more than 13% in Monday morning trading.\n\nVarious companies have been engaged in producing COVID-19 vaccines since the onset of the pandemic.\nClinical-stage biotech firm Ocugen (OCGN) joined the race in December 2020, announcing its partnership with India-based Bharat Biotech. Ocugen collaborated with the Indian biotech company to jointly develop Covaxin.\nThe announcement helped its stock to propel from under 30 cents a share to a stunning, eventual high of $18.77 a share in February. However, prices plummeted to nearly $9 per share in the next month.\nAs rival companies came forward with their vaccines while Ocugen lagged behind, the stock started to bleed.\nHowever, OCGN stock is once again witnessing an upward move. Here’s a detailed analysis to find out what’s really happening with the stock. I’m neutral on Ocugen.\nDelta Variant Concerns Pushing OCGN Stock up\nNewly discovered variants of COVID-19 have been a major cause of concern lately. These variants are more infectious, and resistant, to the already existing COVID-19 vaccines. The Delta variant is one such dangerous strain that has caught the attention of people worldwide.\nThis new variant has piqued global interest in Ocugen, and its Covaxin. Notably, Covaxin is yet to receive approval from FDA. However, the once-forgotten OCGN stock is again back in the discussion, with stock prices moving up by a decent 8.5% in August.\nAccording to many analysts, value investors aren’t interested in this stock. Rather, it is mainly retail investors who are eyeing Ocugen for some quick profit.\nShort-term Catalyst behind the Sudden Spike\nOcugen has been jointly developing Covaxin with Bharat Biotech for use in the North American market. Share prices suffered a decline when Ocugen was denied emergency-use authorization from the FDA, which recommended that the company apply for a biologics-license application instead.\nHealth Canada is reviewing Covaxin currently. It has not yet been granted approval. However, the news of review was enough to push Ocugen stock higher.\nMoreover, the company intends to submit an Investigational New Drug application for one of its gene therapy candidates. OCU400 is designed to target retinal diseases. Ocugen has already started to assess options to begin trials in Europe in 2022.\nOcugen Needs to Progress\nThe biotech company released a much-awaited business update on August 6. Ocugen failed to generate revenue during the second quarter. Unlike many of its rivals, it doesn’t have any commercialized products at the moment.\nOn top of that, it posted a net loss of $26 million during Q2. Expenses related to research and development stood at $18.9 million in the current quarter, as opposed to $1.6 million last year. In addition, administrative expenses increased by 279.8% year-over-year, to $6.8 million.\nAs of June 30, cash and cash equivalents stood at $115.6 million.\nWall Street’s Take\nAs per TipRanks’ analyst rating consensus, Ocugen stock is a Moderate Buy. Out of four analysts, there are two Buy recommendations, and two Hold recommendations.\nThe average OCGN price target is $8.88. The analyst price targets range from a high of $15 per share, to a low of $4.50 per share.\n\nBottom Line\nOcugen stock could very well profit from the mounting global concerns about the Delta variant.\nThere might even be a stock rally. However, the company is badly in need of positive regulatory updates right now.\nIt’s an interesting play, but not without risk.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2013,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888392488,"gmtCreate":1631431444744,"gmtModify":1676530547708,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"$19X&nbsp;by end year","listText":"$19X&nbsp;by end year","text":"$19X by end year","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/888392488","repostId":"2166904370","repostType":4,"isVote":1,"tweetType":1,"viewCount":1945,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":819412201,"gmtCreate":1630086512203,"gmtModify":1676530221959,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"when bitcoin rise back to $60k????","listText":"when bitcoin rise back to $60k????","text":"when bitcoin rise back to $60k????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/819412201","repostId":"1199074003","repostType":4,"repost":{"id":"1199074003","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1630077382,"share":"https://ttm.financial/m/news/1199074003?lang=&edition=fundamental","pubTime":"2021-08-27 23:16","market":"us","language":"en","title":"Crypto stocks surged in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1199074003","media":"Tiger Newspress","summary":"Crypto stocks surged in morning trading.Bit Digital,Marathon Digital,Riot Blockchain,SoS Ltd,Square,","content":"<p>Crypto stocks surged in morning trading.Bit Digital,Marathon Digital,Riot Blockchain,SoS Ltd,Square,Coinbase&nbsp;and&nbsp;Paypal&nbsp;climbed between 1% and 13%.</p>\n<p><img src=\"https://static.tigerbbs.com/67735af69f95f6a88ee67ae3737e58c0\" tg-width=\"364\" tg-height=\"715\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Crypto stocks surged in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrypto stocks surged in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-27 23:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Crypto stocks surged in morning trading.Bit Digital,Marathon Digital,Riot Blockchain,SoS Ltd,Square,Coinbase&nbsp;and&nbsp;Paypal&nbsp;climbed between 1% and 13%.</p>\n<p><img src=\"https://static.tigerbbs.com/67735af69f95f6a88ee67ae3737e58c0\" tg-width=\"364\" tg-height=\"715\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAN":"嘉楠科技","MARA":"MARA Holdings","NCTY":"第九城市","EBON":"亿邦国际","RIOT":"Riot Platforms","COIN":"Coinbase Global, Inc.","BTBT":"Bit Digital, Inc.","SOS":"SOS Limited"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199074003","content_text":"Crypto stocks surged in morning trading.Bit Digital,Marathon Digital,Riot Blockchain,SoS Ltd,Square,Coinbase and Paypal climbed between 1% and 13%.","news_type":1,"symbols_score_info":{"CAN":0.9,"MARA":0.9,"BTBT":0.9,"COIN":0.9,"BTCM":0.9,"RIOT":0.9,"SQ":0.9,"NCTY":0.9,"EBON":0.9,"SOS":0.9}},"isVote":1,"tweetType":1,"viewCount":1155,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3581978054709801","authorId":"3581978054709801","name":"Nickystonks","avatar":"https://community-static.tradeup.com/news/899e00600a95e04d314b62be25a3670f","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3581978054709801","idStr":"3581978054709801"},"content":"maybe. 50k is a resistance level. let's see if it breaks it","text":"maybe. 50k is a resistance level. let's see if it breaks it","html":"maybe. 50k is a resistance level. let's see if it breaks it"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886336965,"gmtCreate":1631549461457,"gmtModify":1676530574165,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"ford should be a $15 share..i wish","listText":"ford should be a $15 share..i wish","text":"ford should be a $15 share..i wish","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/886336965","repostId":"2167658404","repostType":2,"repost":{"id":"2167658404","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1631545694,"share":"https://ttm.financial/m/news/2167658404?lang=&edition=fundamental","pubTime":"2021-09-13 23:08","market":"us","language":"en","title":"Ford Motor Says Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2167658404","media":"T-Reuters","summary":"Ford Motor Co :Ford Motor Co - Mike Amend Starts With Ford Today As The New Chief Digital And Inform","content":"<html><body><p>Ford Motor Co <f.n>:Ford Motor Co - Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer.Further Company Coverage: F.N. ((Reuters.Briefs@Thomsonreuters.Com;)).</f.n></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford Motor Says Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord Motor Says Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-09-13 23:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Ford Motor Co <f.n>:Ford Motor Co - Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer.Further Company Coverage: F.N. ((Reuters.Briefs@Thomsonreuters.Com;)).</f.n></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"III":"信息服务","DLR":"数字房地产信托公司","F":"福特汽车","NGD":"New Gold"},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167658404","content_text":"Ford Motor Co :Ford Motor Co - Mike Amend Starts With Ford Today As The New Chief Digital And Information Officer.Further Company Coverage: F.N. ((Reuters.Briefs@Thomsonreuters.Com;)).","news_type":1,"symbols_score_info":{"DLR":1,"NGD":1,"III":1,"F":1}},"isVote":1,"tweetType":1,"viewCount":2686,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3586655655659820","authorId":"3586655655659820","name":"sunshine138","avatar":"https://static.tigerbbs.com/23149c63a63bfeec1572cc27e1322750","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3586655655659820","idStr":"3586655655659820"},"content":"When will it move there","text":"When will it move there","html":"When will it move there"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814358162,"gmtCreate":1630768928456,"gmtModify":1676530392740,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NIO\">$NIO Inc.(NIO)$</a>hope to reach half Tesla price haha","listText":"<a href=\"https://laohu8.com/S/NIO\">$NIO Inc.(NIO)$</a>hope to reach half Tesla price haha","text":"$NIO Inc.(NIO)$hope to reach half Tesla price haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":1,"link":"https://ttm.financial/post/814358162","isVote":1,"tweetType":1,"viewCount":2774,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","crmLevel":12,"crmLevelSwitch":1,"authorIdStr":"3559581955535845","idStr":"3559581955535845"},"content":"Nio to the moon??????","text":"Nio to the moon??????","html":"Nio to the moon??????"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863229400,"gmtCreate":1632400374400,"gmtModify":1676530772716,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"Pfizer can reach $50 by Oct....i wish","listText":"Pfizer can reach $50 by Oct....i wish","text":"Pfizer can reach $50 by Oct....i wish","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/863229400","repostId":"1133566174","repostType":4,"repost":{"id":"1133566174","kind":"news","pubTimestamp":1632397453,"share":"https://ttm.financial/m/news/1133566174?lang=&edition=fundamental","pubTime":"2021-09-23 19:44","market":"us","language":"en","title":"Despite Vaccine Uncertainty, Pfizer Is a Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=1133566174","media":"InvestorPlace","summary":"Forget the booster shot controversy, PFE stock has better days ahead.\n\nWhat would happen if a compan","content":"<div>\n<p>Forget the booster shot controversy, PFE stock has better days ahead.\n\nWhat would happen if a company developed a massive new product and no one cared? For Pfizer’s investors, that has been the ...</p>\n\n<a href=\"https://investorplace.com/2021/09/despite-vaccine-uncertainty-pfizer-is-a-buy/\">Web Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Despite Vaccine Uncertainty, Pfizer Is a Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDespite Vaccine Uncertainty, Pfizer Is a Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 19:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/09/despite-vaccine-uncertainty-pfizer-is-a-buy/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Forget the booster shot controversy, PFE stock has better days ahead.\n\nWhat would happen if a company developed a massive new product and no one cared? For Pfizer’s investors, that has been the ...</p>\n\n<a href=\"https://investorplace.com/2021/09/despite-vaccine-uncertainty-pfizer-is-a-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://investorplace.com/2021/09/despite-vaccine-uncertainty-pfizer-is-a-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133566174","content_text":"Forget the booster shot controversy, PFE stock has better days ahead.\n\nWhat would happen if a company developed a massive new product and no one cared? For Pfizer’s investors, that has been the question for the past year. Despite coming up with a blockbuster vaccine for the novel coronavirus, PFE stock did basically nothing for an extended period.\nThat finally changed this summer, when Pfizer belatedly rallied to new all-time highs. Now though, the gains are fading almost as quickly as they happened. In its Q2 earnings release, Pfizer reported 93% year-over-year revenue growth. Yet shares are up less than 20% over the past 12 months. Why have investors not given Pfizer credit for its performance, and will that change in the future?\nVaccine Hits A Setback\nPfizer has enjoyed incredible revenue growth over the past year due to its Covid-19 vaccine. The majority of vaccinated American adults have taken the Pfizer vaccine, and it’s had strong sales overseas as well.\nDespite that, however, PFE stock didn’t move too much. At least, not until July of this year. At that time, PFE stock finally took off. The reason why is that investors started to price in the expectation that people would need to take vaccine booster shots to maintain efficacy.\nThe idea of a third, and potentially even fourth or more dose of vaccines would have created a far more enduring revenue boost for Pfizer. Up until recently, investors had shied away from Pfizer despite its massive top-line growth because they anticipated that the Covid business would quickly recede. With booster shots, however, the vaccine would have taken on another level of importance to the company.\nThis scenario is now under increasing doubt, however. A Food and Drug Administration (FDA) advisory panel recentlyrecommended againstadvising booster shots of the Pfizer vaccine. A large majority of the panelists voted that the data on hand was insufficient to warrant booster shots. That comes amid reports that Moderna’s(NASDAQ:MRNA) vaccine remains effective in a higher percentage of people than Pfizer’s after 120 days.\nThis is hardly the final word on booster shots or the efficacy of Moderna versus Pfizer. Pfizer’s investors shouldn’t discount the possibility that the FDA later comes around on additional rounds of the vaccine. For now, however, the prospects are looking more uncertain.\nBaseline Valuation Is Not That Demanding\nLet’s go back in time to 2019 and pretend that we’ve never heard of the pandemic. What does an investment in Pfizer look like in this hypothetical scenario? For full-year 2018, Pfizer generated $1.87 of EPS. In 2019, this leapt to $2.87.\nBased on today’s stock price just below $44, PFE stock is selling at 23x 2018 earnings or 15x 2019 earnings. With no benefit from the current Covid-19 vaccine whatsoever, Pfizer stock would still be going for a reasonable multiple.\nYes, you can argue that pharmaceutical companies should trade for lower P/E multiples than many other industries given the high cost of drug development and quick patent expiries. Still, with earnings as strong as they were in 2018-19, it’s not hard to get behind the stock at $44 even if you give the company zero credit for the Covid-19 vaccine. Forget about booster shots for a minute, traders are pricing Pfizer like there will be little more revenue from the vaccine whatsoever.\nPFE Stock Verdict\nRight now, Pfizer stock is inextricably linked to its vaccine’s outlook. When there is positive news on that front, PFE stock surges. When there is a setback, PFE stock sells off hard. That’s a totally understandable market reaction. Many traders are trained to react quickly to the latest headline.\nFor longer-term investors, however, Pfizer is an opportunity regardless of the trajectory of the vaccine. Even if boosters ultimately aren’t a big thing, Pfizer can still make investors money from this entry point.\nThe company is a tremendous diversified pharmaceutical giant. It was in good shape long before the pandemic, and it has dozens of promising drugs in its pipeline to power it for the next decade and beyond. The company is reaping a windfall right now, but it’s not like that’s its only iron in the fire.\nIf the Covid-19 business continues longer than forecast, that’s all upside to the stock price. However, from this starting point, there’s sufficient margin of safety to support a purchase in most possible outcomes.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2958,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4092216435500580","authorId":"4092216435500580","name":"SimonSim","avatar":"https://static.tigerbbs.com/f2870d5ab54ba75f2d74ad8cb044473a","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"4092216435500580","idStr":"4092216435500580"},"content":"[Happy] [Happy] [Happy]","text":"[Happy] [Happy] [Happy]","html":"[Happy] [Happy] [Happy]"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869784588,"gmtCreate":1632322282944,"gmtModify":1676530752993,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"Maybe&nbsp;Apple can consider learn from Xiaomi,sell Smart systems on almost everything from robot vaccum to humidifier haha....","listText":"Maybe&nbsp;Apple can consider learn from Xiaomi,sell Smart systems on almost everything from robot vaccum to humidifier haha....","text":"Maybe Apple can consider learn from Xiaomi,sell Smart systems on almost everything from robot vaccum to humidifier haha....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/869784588","repostId":"1143821004","repostType":4,"isVote":1,"tweetType":1,"viewCount":2498,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3580536610076415","authorId":"3580536610076415","name":"BettyT","avatar":"https://static.tigerbbs.com/6a4dfe2f455acd2af7629f83ce30e20c","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3580536610076415","idStr":"3580536610076415"},"content":"diversified ? Haha ??","text":"diversified ? Haha ??","html":"diversified ? Haha ??"},{"author":{"id":"3582064943200061","authorId":"3582064943200061","name":"EPK","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3582064943200061","idStr":"3582064943200061"},"content":"Seems like only Xiaomi on thIs Strategy for now?","text":"Seems like only Xiaomi on thIs Strategy for now?","html":"Seems like only Xiaomi on thIs Strategy for now?"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819418625,"gmtCreate":1630086116667,"gmtModify":1676530221910,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"when nio xpeng rise to$50???","listText":"when nio xpeng rise to$50???","text":"when nio xpeng rise to$50???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/819418625","repostId":"2162021329","repostType":4,"isVote":1,"tweetType":1,"viewCount":959,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":443584920121824,"gmtCreate":1749319677111,"gmtModify":1749319681003,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SOFI\">$SoFi Technologies Inc.(SOFI)$ </a> hard earn","listText":"<a href=\"https://ttm.financial/S/SOFI\">$SoFi Technologies Inc.(SOFI)$ </a> hard earn","text":"$SoFi Technologies Inc.(SOFI)$ hard earn","images":[{"img":"https://community-static.tradeup.com/news/0000051583073749b0dc7c24f4f1981e","width":"1080","height":"2908"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/443584920121824","isVote":1,"tweetType":1,"viewCount":1229,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":818294685,"gmtCreate":1630411172447,"gmtModify":1676530295627,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"Alibaba or Sea Ltd reach $500 first??","listText":"Alibaba or Sea Ltd reach $500 first??","text":"Alibaba or Sea Ltd reach $500 first??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818294685","repostId":"2163859671","repostType":4,"isVote":1,"tweetType":1,"viewCount":1859,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":444926632477088,"gmtCreate":1749648867590,"gmtModify":1749648871497,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SOFI\">$SoFi Technologies Inc.(SOFI)$ </a> finally over","listText":"<a href=\"https://ttm.financial/S/SOFI\">$SoFi Technologies Inc.(SOFI)$ </a> finally over","text":"$SoFi Technologies Inc.(SOFI)$ finally over","images":[{"img":"https://community-static.tradeup.com/news/c501dc33f6293bf4da70e39fead47cb7","width":"1080","height":"2834"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/444926632477088","isVote":1,"tweetType":1,"viewCount":1112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":863228838,"gmtCreate":1632400543624,"gmtModify":1676530772779,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"Nio niu (bull)ah!","listText":"Nio niu (bull)ah!","text":"Nio niu (bull)ah!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/863228838","repostId":"1135139549","repostType":4,"repost":{"id":"1135139549","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1632386313,"share":"https://ttm.financial/m/news/1135139549?lang=&edition=fundamental","pubTime":"2021-09-23 16:38","market":"us","language":"en","title":"Nio Said To Delay Unveiling Of ES8, Nio House In Norway By A Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1135139549","media":"Benzinga","summary":"Chinese electric vehicle maker NIO Inc. is delaying the official launch of the ES8 SUV and the openi","content":"<p>Chinese electric vehicle maker&nbsp;<b><a href=\"https://laohu8.com/S/NIO\">NIO Inc.</a></b> is delaying the official launch of the ES8 SUV and the opening of the first overseas&nbsp;<b>Nio House</b>&nbsp;in Norway by a week, cnEVpostreportedWednesday.</p>\n<p><b>What Happened</b>: Nio will now launch the ES8 in Norway on Sept. 30 while the first local Nio House in Oslo will be officially open for business from Oct. 1, as per the report that&nbsp;<b>Marius Hayler</b>, general manager of Nio Norway.</p>\n<p>The report did not provide any details about the reasons for the delay. It was&nbsp;reported&nbsp;earlier this month the EV maker will open the Nio House in Norway and also announce the local pricing of its flagship ES8 model on Sept. 23.</p>\n<p>Nio House is the EV maker’s concept store.</p>\n<p><b>Why It Matters</b>: &nbsp;Nio’s entry into Norway marks the first step in an ambitious overseas expansion plan charted by the EV maker, which has found success in <a href=\"https://laohu8.com/S/CAAS\">China</a> as a seller of premium electric vehicles.</p>\n<p>NIO CEO<b>Wiliam Li</b>has said that the company may expand into Germany, followed by other European countries, if it achieves success in Norway.</p>\n<p><b>Price Action</b>: Nio shares closed almost 2.3% higher in Wednesday’s trading at $35.70.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nio Said To Delay Unveiling Of ES8, Nio House In Norway By A Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNio Said To Delay Unveiling Of ES8, Nio House In Norway By A Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-23 16:38</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Chinese electric vehicle maker&nbsp;<b><a href=\"https://laohu8.com/S/NIO\">NIO Inc.</a></b> is delaying the official launch of the ES8 SUV and the opening of the first overseas&nbsp;<b>Nio House</b>&nbsp;in Norway by a week, cnEVpostreportedWednesday.</p>\n<p><b>What Happened</b>: Nio will now launch the ES8 in Norway on Sept. 30 while the first local Nio House in Oslo will be officially open for business from Oct. 1, as per the report that&nbsp;<b>Marius Hayler</b>, general manager of Nio Norway.</p>\n<p>The report did not provide any details about the reasons for the delay. It was&nbsp;reported&nbsp;earlier this month the EV maker will open the Nio House in Norway and also announce the local pricing of its flagship ES8 model on Sept. 23.</p>\n<p>Nio House is the EV maker’s concept store.</p>\n<p><b>Why It Matters</b>: &nbsp;Nio’s entry into Norway marks the first step in an ambitious overseas expansion plan charted by the EV maker, which has found success in <a href=\"https://laohu8.com/S/CAAS\">China</a> as a seller of premium electric vehicles.</p>\n<p>NIO CEO<b>Wiliam Li</b>has said that the company may expand into Germany, followed by other European countries, if it achieves success in Norway.</p>\n<p><b>Price Action</b>: Nio shares closed almost 2.3% higher in Wednesday’s trading at $35.70.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135139549","content_text":"Chinese electric vehicle maker NIO Inc. is delaying the official launch of the ES8 SUV and the opening of the first overseas Nio House in Norway by a week, cnEVpostreportedWednesday.\nWhat Happened: Nio will now launch the ES8 in Norway on Sept. 30 while the first local Nio House in Oslo will be officially open for business from Oct. 1, as per the report that Marius Hayler, general manager of Nio Norway.\nThe report did not provide any details about the reasons for the delay. It was reported earlier this month the EV maker will open the Nio House in Norway and also announce the local pricing of its flagship ES8 model on Sept. 23.\nNio House is the EV maker’s concept store.\nWhy It Matters:  Nio’s entry into Norway marks the first step in an ambitious overseas expansion plan charted by the EV maker, which has found success in China as a seller of premium electric vehicles.\nNIO CEOWiliam Lihas said that the company may expand into Germany, followed by other European countries, if it achieves success in Norway.\nPrice Action: Nio shares closed almost 2.3% higher in Wednesday’s trading at $35.70.","news_type":1,"symbols_score_info":{"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":2697,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836602761,"gmtCreate":1629473057753,"gmtModify":1676530054050,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"when sundial rises????","listText":"when sundial rises????","text":"when sundial rises????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/836602761","repostId":"2160710591","repostType":4,"isVote":1,"tweetType":1,"viewCount":1015,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886333560,"gmtCreate":1631549154550,"gmtModify":1676530574110,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"sold first maybe buy later &lt;8,pls like n share your comments&nbsp;thanks","listText":"sold first maybe buy later &lt;8,pls like n share your comments&nbsp;thanks","text":"sold first maybe buy later <8,pls like n share your comments thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/886333560","repostId":"1126978010","repostType":4,"repost":{"id":"1126978010","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631544701,"share":"https://ttm.financial/m/news/1126978010?lang=&edition=fundamental","pubTime":"2021-09-13 22:51","market":"us","language":"en","title":"Ocugen shares surged more than 13% in Monday morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1126978010","media":"Tiger Newspress","summary":"Ocugen shares surged more than 13% in Monday morning trading.\n\nVarious companies have been engaged i","content":"<p>Ocugen shares surged more than 13%&nbsp;in Monday morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/8fcba6c91ee88af0dd90608a79065282\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Various companies have been engaged in producing COVID-19 vaccines since the onset of the pandemic.</p>\n<p>Clinical-stage biotech firm Ocugen (<b>OCGN</b>) joined the race in December 2020, announcing its partnership with India-based Bharat Biotech. Ocugen collaborated with the Indian biotech company to jointly develop Covaxin.</p>\n<p>The announcement helped its stock to propel from under 30 cents a share to a stunning, eventual high of&nbsp;$18.77 a share in February. However, prices plummeted to nearly $9 per share in the next month.</p>\n<p>As rival companies came forward with their vaccines while Ocugen lagged behind, the stock started to bleed.</p>\n<p>However, OCGN stock is once again witnessing an upward move. Here’s a detailed analysis to find out what’s really happening with the stock. I’m neutral on Ocugen.</p>\n<p><b>Delta Variant Concerns Pushing OCGN Stock up</b></p>\n<p>Newly discovered variants of COVID-19 have been a major cause of concern lately. These variants are more infectious, and resistant, to the already existing COVID-19 vaccines. The Delta variant is one such dangerous strain that has caught the attention of people worldwide.</p>\n<p>This new variant has piqued global interest in Ocugen, and its Covaxin. Notably, Covaxin is yet to receive approval from FDA. However, the once-forgotten OCGN stock is again back in the discussion, with stock prices moving up by a decent 8.5% in August.</p>\n<p>According to many analysts, value investors aren’t interested in this stock. Rather, it is mainly retail investors who are eyeing Ocugen for some quick profit.</p>\n<p><b>Short-term Catalyst behind the Sudden Spike</b></p>\n<p>Ocugen has been jointly developing Covaxin with Bharat Biotech for use in the North American market. Share prices suffered a decline when Ocugen was denied emergency-use authorization from the FDA, which recommended that the company apply for a biologics-license application instead.</p>\n<p>Health Canada is reviewing Covaxin currently. It has not yet been granted approval. However, the news of review was enough to push Ocugen stock higher.</p>\n<p>Moreover, the company intends to submit an Investigational New Drug application for one of its gene therapy candidates. OCU400 is designed to target retinal diseases. Ocugen has already started to assess options to begin trials in Europe in 2022.</p>\n<p><b>Ocugen Needs to Progress</b></p>\n<p>The biotech company released a much-awaited business update on August 6. Ocugen failed to generate revenue during the second quarter. Unlike many of its rivals, it doesn’t have any commercialized products at the moment.</p>\n<p>On top of that, it posted a&nbsp;net loss of $26 million during Q2. Expenses related to research and development stood at $18.9 million in the current quarter, as opposed to $1.6 million last year. In addition, administrative expenses increased by 279.8% year-over-year, to $6.8 million.</p>\n<p>As of June 30, cash and cash equivalents stood at $115.6 million.</p>\n<p><b>Wall Street’s Take</b></p>\n<p>As per TipRanks’ analyst rating consensus, Ocugen stock is a Moderate Buy. Out of four analysts, there are two Buy recommendations, and two Hold recommendations.</p>\n<p>The&nbsp;average OCGN price target&nbsp;is $8.88. The analyst price targets range from a high of $15 per share, to a low of $4.50 per share.</p>\n<p><img src=\"https://static.tigerbbs.com/9c696ea686fdeaa8d6550e1282efebf7\" tg-width=\"1099\" tg-height=\"374\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Bottom Line</b></p>\n<p>Ocugen stock could very well profit from the mounting global concerns about the Delta variant.</p>\n<p>There might even be a stock rally. However, the company is badly in need of positive regulatory updates right now.</p>\n<p>It’s an interesting play, but not without risk.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen shares surged more than 13% in Monday morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen shares surged more than 13% in Monday morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-13 22:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen shares surged more than 13%&nbsp;in Monday morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/8fcba6c91ee88af0dd90608a79065282\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Various companies have been engaged in producing COVID-19 vaccines since the onset of the pandemic.</p>\n<p>Clinical-stage biotech firm Ocugen (<b>OCGN</b>) joined the race in December 2020, announcing its partnership with India-based Bharat Biotech. Ocugen collaborated with the Indian biotech company to jointly develop Covaxin.</p>\n<p>The announcement helped its stock to propel from under 30 cents a share to a stunning, eventual high of&nbsp;$18.77 a share in February. However, prices plummeted to nearly $9 per share in the next month.</p>\n<p>As rival companies came forward with their vaccines while Ocugen lagged behind, the stock started to bleed.</p>\n<p>However, OCGN stock is once again witnessing an upward move. Here’s a detailed analysis to find out what’s really happening with the stock. I’m neutral on Ocugen.</p>\n<p><b>Delta Variant Concerns Pushing OCGN Stock up</b></p>\n<p>Newly discovered variants of COVID-19 have been a major cause of concern lately. These variants are more infectious, and resistant, to the already existing COVID-19 vaccines. The Delta variant is one such dangerous strain that has caught the attention of people worldwide.</p>\n<p>This new variant has piqued global interest in Ocugen, and its Covaxin. Notably, Covaxin is yet to receive approval from FDA. However, the once-forgotten OCGN stock is again back in the discussion, with stock prices moving up by a decent 8.5% in August.</p>\n<p>According to many analysts, value investors aren’t interested in this stock. Rather, it is mainly retail investors who are eyeing Ocugen for some quick profit.</p>\n<p><b>Short-term Catalyst behind the Sudden Spike</b></p>\n<p>Ocugen has been jointly developing Covaxin with Bharat Biotech for use in the North American market. Share prices suffered a decline when Ocugen was denied emergency-use authorization from the FDA, which recommended that the company apply for a biologics-license application instead.</p>\n<p>Health Canada is reviewing Covaxin currently. It has not yet been granted approval. However, the news of review was enough to push Ocugen stock higher.</p>\n<p>Moreover, the company intends to submit an Investigational New Drug application for one of its gene therapy candidates. OCU400 is designed to target retinal diseases. Ocugen has already started to assess options to begin trials in Europe in 2022.</p>\n<p><b>Ocugen Needs to Progress</b></p>\n<p>The biotech company released a much-awaited business update on August 6. Ocugen failed to generate revenue during the second quarter. Unlike many of its rivals, it doesn’t have any commercialized products at the moment.</p>\n<p>On top of that, it posted a&nbsp;net loss of $26 million during Q2. Expenses related to research and development stood at $18.9 million in the current quarter, as opposed to $1.6 million last year. In addition, administrative expenses increased by 279.8% year-over-year, to $6.8 million.</p>\n<p>As of June 30, cash and cash equivalents stood at $115.6 million.</p>\n<p><b>Wall Street’s Take</b></p>\n<p>As per TipRanks’ analyst rating consensus, Ocugen stock is a Moderate Buy. Out of four analysts, there are two Buy recommendations, and two Hold recommendations.</p>\n<p>The&nbsp;average OCGN price target&nbsp;is $8.88. The analyst price targets range from a high of $15 per share, to a low of $4.50 per share.</p>\n<p><img src=\"https://static.tigerbbs.com/9c696ea686fdeaa8d6550e1282efebf7\" tg-width=\"1099\" tg-height=\"374\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Bottom Line</b></p>\n<p>Ocugen stock could very well profit from the mounting global concerns about the Delta variant.</p>\n<p>There might even be a stock rally. However, the company is badly in need of positive regulatory updates right now.</p>\n<p>It’s an interesting play, but not without risk.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126978010","content_text":"Ocugen shares surged more than 13% in Monday morning trading.\n\nVarious companies have been engaged in producing COVID-19 vaccines since the onset of the pandemic.\nClinical-stage biotech firm Ocugen (OCGN) joined the race in December 2020, announcing its partnership with India-based Bharat Biotech. Ocugen collaborated with the Indian biotech company to jointly develop Covaxin.\nThe announcement helped its stock to propel from under 30 cents a share to a stunning, eventual high of $18.77 a share in February. However, prices plummeted to nearly $9 per share in the next month.\nAs rival companies came forward with their vaccines while Ocugen lagged behind, the stock started to bleed.\nHowever, OCGN stock is once again witnessing an upward move. Here’s a detailed analysis to find out what’s really happening with the stock. I’m neutral on Ocugen.\nDelta Variant Concerns Pushing OCGN Stock up\nNewly discovered variants of COVID-19 have been a major cause of concern lately. These variants are more infectious, and resistant, to the already existing COVID-19 vaccines. The Delta variant is one such dangerous strain that has caught the attention of people worldwide.\nThis new variant has piqued global interest in Ocugen, and its Covaxin. Notably, Covaxin is yet to receive approval from FDA. However, the once-forgotten OCGN stock is again back in the discussion, with stock prices moving up by a decent 8.5% in August.\nAccording to many analysts, value investors aren’t interested in this stock. Rather, it is mainly retail investors who are eyeing Ocugen for some quick profit.\nShort-term Catalyst behind the Sudden Spike\nOcugen has been jointly developing Covaxin with Bharat Biotech for use in the North American market. Share prices suffered a decline when Ocugen was denied emergency-use authorization from the FDA, which recommended that the company apply for a biologics-license application instead.\nHealth Canada is reviewing Covaxin currently. It has not yet been granted approval. However, the news of review was enough to push Ocugen stock higher.\nMoreover, the company intends to submit an Investigational New Drug application for one of its gene therapy candidates. OCU400 is designed to target retinal diseases. Ocugen has already started to assess options to begin trials in Europe in 2022.\nOcugen Needs to Progress\nThe biotech company released a much-awaited business update on August 6. Ocugen failed to generate revenue during the second quarter. Unlike many of its rivals, it doesn’t have any commercialized products at the moment.\nOn top of that, it posted a net loss of $26 million during Q2. Expenses related to research and development stood at $18.9 million in the current quarter, as opposed to $1.6 million last year. In addition, administrative expenses increased by 279.8% year-over-year, to $6.8 million.\nAs of June 30, cash and cash equivalents stood at $115.6 million.\nWall Street’s Take\nAs per TipRanks’ analyst rating consensus, Ocugen stock is a Moderate Buy. Out of four analysts, there are two Buy recommendations, and two Hold recommendations.\nThe average OCGN price target is $8.88. The analyst price targets range from a high of $15 per share, to a low of $4.50 per share.\n\nBottom Line\nOcugen stock could very well profit from the mounting global concerns about the Delta variant.\nThere might even be a stock rally. However, the company is badly in need of positive regulatory updates right now.\nIt’s an interesting play, but not without risk.","news_type":1,"symbols_score_info":{"OCGN":0.9}},"isVote":1,"tweetType":1,"viewCount":2013,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819416733,"gmtCreate":1630086304922,"gmtModify":1676530221943,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"when nio xpeng rise to $50???","listText":"when nio xpeng rise to $50???","text":"when nio xpeng rise to $50???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/819416733","repostId":"1165379113","repostType":4,"repost":{"id":"1165379113","kind":"news","pubTimestamp":1630075265,"share":"https://ttm.financial/m/news/1165379113?lang=&edition=fundamental","pubTime":"2021-08-27 22:41","market":"us","language":"en","title":"Tesla Wants to Become an Electricity Retailer in Texas. What To Know.","url":"https://stock-news.laohu8.com/highlight/detail?id=1165379113","media":"Barrons","summary":"A Tesla subsidiary has applied to become an electricity retailer in Texas, moving to widen the energ","content":"<p>A Tesla subsidiary has applied to become an electricity retailer in Texas, moving to widen the energy ambitions of Elon Musk’s electric-vehicle company in a state with a power grid that came under scrutiny after failing in a February winter storm.</p>\n<p>Tesla Energy Ventures, a subsidiary of Tesla formed in late July, wants to sell power directly to customers as a retail electricity provider, according to an August 16 filing with the Texas Public Utility Commission.</p>\n<p>Shares in Tesla were 0.6% higher in U.S. premarket trading on Friday, outpacing a rise in futures for the&nbsp;Nasdaq 100&nbsp;index, of which Tesla is a component.</p>\n<p>Tesla also intends to build two massive utility-scale batteries to serve power companies in the state, according to Texas Monthly,which first reported the news&nbsp;on Thursday and said that the filing could be approved by November.</p>\n<p>One of those batteries would reportedly be located at a gigafactory outside Austin, where the Cybertruck and Model Y SUV are slated to be built, with another located outside Houston,based on a report from Bloomberg.</p>\n<p>Texas’ deregulated power grid includes well over 100 companies selling to consumers. The state’s power system came under the spotlight this winter, when&nbsp;a February storm&nbsp;left millions without electricity for several days.</p>\n<p>Tesla hoped to enter the Texas power market earlier, before the widespread blackouts in February, according to the Texas Monthly report.</p>\n<p>The company has a history of building utility-scale power storage, with developments in California and Australia, but becoming an electricity retailer in Texas would be a significant milestone in the expansion of Tesla’s energy division.</p>\n<p>“I can’t emphasize enough, I think long term, Tesla Energy will be of roughly the same size as Tesla Automotive,” Musk told investors last summer, after the company’s second-quarter earnings in July 2020.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Wants to Become an Electricity Retailer in Texas. What To Know.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Wants to Become an Electricity Retailer in Texas. What To Know.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 22:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-wants-to-become-an-electricity-retailer-in-texas-what-to-know-51630066304?mod=hp_DAY_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A Tesla subsidiary has applied to become an electricity retailer in Texas, moving to widen the energy ambitions of Elon Musk’s electric-vehicle company in a state with a power grid that came under ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-wants-to-become-an-electricity-retailer-in-texas-what-to-know-51630066304?mod=hp_DAY_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-wants-to-become-an-electricity-retailer-in-texas-what-to-know-51630066304?mod=hp_DAY_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165379113","content_text":"A Tesla subsidiary has applied to become an electricity retailer in Texas, moving to widen the energy ambitions of Elon Musk’s electric-vehicle company in a state with a power grid that came under scrutiny after failing in a February winter storm.\nTesla Energy Ventures, a subsidiary of Tesla formed in late July, wants to sell power directly to customers as a retail electricity provider, according to an August 16 filing with the Texas Public Utility Commission.\nShares in Tesla were 0.6% higher in U.S. premarket trading on Friday, outpacing a rise in futures for the Nasdaq 100 index, of which Tesla is a component.\nTesla also intends to build two massive utility-scale batteries to serve power companies in the state, according to Texas Monthly,which first reported the news on Thursday and said that the filing could be approved by November.\nOne of those batteries would reportedly be located at a gigafactory outside Austin, where the Cybertruck and Model Y SUV are slated to be built, with another located outside Houston,based on a report from Bloomberg.\nTexas’ deregulated power grid includes well over 100 companies selling to consumers. The state’s power system came under the spotlight this winter, when a February storm left millions without electricity for several days.\nTesla hoped to enter the Texas power market earlier, before the widespread blackouts in February, according to the Texas Monthly report.\nThe company has a history of building utility-scale power storage, with developments in California and Australia, but becoming an electricity retailer in Texas would be a significant milestone in the expansion of Tesla’s energy division.\n“I can’t emphasize enough, I think long term, Tesla Energy will be of roughly the same size as Tesla Automotive,” Musk told investors last summer, after the company’s second-quarter earnings in July 2020.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":966,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835513111,"gmtCreate":1629726602833,"gmtModify":1676530112928,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"pfizer up up","listText":"pfizer up up","text":"pfizer up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/835513111","repostId":"1132832038","repostType":4,"repost":{"id":"1132832038","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629720645,"share":"https://ttm.financial/m/news/1132832038?lang=&edition=fundamental","pubTime":"2021-08-23 20:10","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1132832038","media":"Tiger Newspress","summary":"Futures rebound as oil stocks jump; PMI data in focus\n\n\nBitcoin rises above $50,000; crypto stocks r","content":"<ul>\n <li>Futures rebound as oil stocks jump; PMI data in focus</li>\n</ul>\n<ul>\n <li>Bitcoin rises above $50,000; crypto stocks rallies</li>\n</ul>\n<p>U.S. stock index futures rose on Monday, with oil shares leading the pack, as investors returned to riskier assets after a sharp selloff last week on worries about a slowing pace of U.S. economic growth.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 160 points, or 0.46%, S&amp;P 500 e-minis were up 15.5 points, or 0.35%, and Nasdaq 100 e-minis were up 47.25 points, or 0.31%.</p>\n<p><img src=\"https://static.tigerbbs.com/a9448ca2bf64498be143abe1a2cad2ec\" tg-width=\"1080\" tg-height=\"373\" referrerpolicy=\"no-referrer\"></p>\n<p>Apple Inc, Amazon.com&nbsp;and Tesla Inc&nbsp;were all up between 0.3% and 1% before the opening bell.</p>\n<p>Oil majors Chevron Corp, Exxon Mobil, Schlumberger NV&nbsp;and Occidental Petroleum&nbsp;gained between 2% and 3.6% in premarket trading, tracking a 3% jump in crude prices.</p>\n<p>IHS-Markit's flash reading of U.S. business activity, due at 9:45 a.m. ET, is expected to retreat in August to 58.3 from 59.9 in July.</p>\n<p>Focus is now on the Fed's annual economic symposium in Jackson Hole, Wyoming, for more insight on the timeline for the central bank's tapering of its asset purchases. The summit will be held virtually on Aug. 27 for the second straight year.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p>Boeing(BA) – Boeing added 1.4% in the premarket, following news that it planned to invest in a SPAC merger planned later this year by Richard Branson’s satellite launch company Virgin Orbit. Virgin Orbit plans to merge with blank-check companyNextGen Acquisition(XOS), whose shares jumped 6% following the announcement.</p>\n<p>Coinbase(COIN) – Coinbase jumped 3.6% in premarket trading, with the cryptocurrency exchange’s stock benefiting from bitcoin rising to its highest level since early May. Shares of the business analytics company&nbsp;MicroStrategy(MSTR) – which has extensive bitcoin holdings – rallied 3.9%.</p>\n<p>Pfizer(PFE),BioNTech(BNTX) – The drug makers are expected to receive full FDA approval for their Covid-19 vaccine as soon as today, according to multiple reports. The vaccine had received emergency use authorization in late 2020. Pfizer added 3.3% in premarket action while BioNTech surged 7.1%.Moderna(MRNA) is also in the process of applying for full FDA approval of its Covid-19 vaccine and its shares rose 2.7%.</p>\n<p>Trillium Therapeutics(TRIL) – Pfizer said it would buy the portion of the cancer therapy specialist that it doesn’t already own in a deal worth $2.26 billion or $18.50 per share in cash. That compares to Trillium’s Friday close of $6.09 per share. Pfizer had invested $25 million in Trillium in September 2020. Trillium shares nearly tripled in premarket trading.</p>\n<p>General Motors(GM) – General Motors expanded the recall of its Chevy Bolt electric car to include newer models, a move that will cost the automaker an additional $1 billion. The recall will address an issue that can increase the risk of battery fires. GM fell 1.5% in the premarket.</p>\n<p>Uber(UBER),Lyft(LYFT),DoorDash(DASH) – These stocks are on watch after a California judge ruled the state’s “gig workers” law was unconstitutional. California voters had approved a ballot measure last November allowing those companies to treat workers as independent contractors rather than employees. The companies – which lobbied extensively for passage of the measure – plan to appeal. Uber tumbled 4.2% in premarket trading, with Lyft sliding 5.1% and DoorDash also losing 2.2%.</p>\n<p>PayPal(PYPL) – PayPal will allow customers in the UK to buy, hold and sell cryptocurrencies beginning this week, its first rollout of cryptocurrency services outside the United States. PayPal added 1% in the premarket.</p>\n<p>Robinhood(HOOD) – The company behind the popular trading app was added to coverage at a handful of investment firms following its late July initial public offering, including Goldman Sachs (neutral rating), Mizuho (buy), JMP Securities (outperform), Barclays (equal weight) and Piper Sandler (neutral). Robinhood added 3.7% in the premarket.</p>\n<p>JD.com(JD) – The Chinese e-commerce company reported better-than-expected profit and revenue for the second quarter while adding a record number of new users.</p>\n<p>Walt Disney Co(DIS)&nbsp; –&nbsp;Walt Disney&nbsp;rose 0.9% after the media company raked in $125 million in online revenue from Marvel superhero film \"Black Widow\".</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-23 20:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Futures rebound as oil stocks jump; PMI data in focus</li>\n</ul>\n<ul>\n <li>Bitcoin rises above $50,000; crypto stocks rallies</li>\n</ul>\n<p>U.S. stock index futures rose on Monday, with oil shares leading the pack, as investors returned to riskier assets after a sharp selloff last week on worries about a slowing pace of U.S. economic growth.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 160 points, or 0.46%, S&amp;P 500 e-minis were up 15.5 points, or 0.35%, and Nasdaq 100 e-minis were up 47.25 points, or 0.31%.</p>\n<p><img src=\"https://static.tigerbbs.com/a9448ca2bf64498be143abe1a2cad2ec\" tg-width=\"1080\" tg-height=\"373\" referrerpolicy=\"no-referrer\"></p>\n<p>Apple Inc, Amazon.com&nbsp;and Tesla Inc&nbsp;were all up between 0.3% and 1% before the opening bell.</p>\n<p>Oil majors Chevron Corp, Exxon Mobil, Schlumberger NV&nbsp;and Occidental Petroleum&nbsp;gained between 2% and 3.6% in premarket trading, tracking a 3% jump in crude prices.</p>\n<p>IHS-Markit's flash reading of U.S. business activity, due at 9:45 a.m. ET, is expected to retreat in August to 58.3 from 59.9 in July.</p>\n<p>Focus is now on the Fed's annual economic symposium in Jackson Hole, Wyoming, for more insight on the timeline for the central bank's tapering of its asset purchases. The summit will be held virtually on Aug. 27 for the second straight year.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p>Boeing(BA) – Boeing added 1.4% in the premarket, following news that it planned to invest in a SPAC merger planned later this year by Richard Branson’s satellite launch company Virgin Orbit. Virgin Orbit plans to merge with blank-check companyNextGen Acquisition(XOS), whose shares jumped 6% following the announcement.</p>\n<p>Coinbase(COIN) – Coinbase jumped 3.6% in premarket trading, with the cryptocurrency exchange’s stock benefiting from bitcoin rising to its highest level since early May. Shares of the business analytics company&nbsp;MicroStrategy(MSTR) – which has extensive bitcoin holdings – rallied 3.9%.</p>\n<p>Pfizer(PFE),BioNTech(BNTX) – The drug makers are expected to receive full FDA approval for their Covid-19 vaccine as soon as today, according to multiple reports. The vaccine had received emergency use authorization in late 2020. Pfizer added 3.3% in premarket action while BioNTech surged 7.1%.Moderna(MRNA) is also in the process of applying for full FDA approval of its Covid-19 vaccine and its shares rose 2.7%.</p>\n<p>Trillium Therapeutics(TRIL) – Pfizer said it would buy the portion of the cancer therapy specialist that it doesn’t already own in a deal worth $2.26 billion or $18.50 per share in cash. That compares to Trillium’s Friday close of $6.09 per share. Pfizer had invested $25 million in Trillium in September 2020. Trillium shares nearly tripled in premarket trading.</p>\n<p>General Motors(GM) – General Motors expanded the recall of its Chevy Bolt electric car to include newer models, a move that will cost the automaker an additional $1 billion. The recall will address an issue that can increase the risk of battery fires. GM fell 1.5% in the premarket.</p>\n<p>Uber(UBER),Lyft(LYFT),DoorDash(DASH) – These stocks are on watch after a California judge ruled the state’s “gig workers” law was unconstitutional. California voters had approved a ballot measure last November allowing those companies to treat workers as independent contractors rather than employees. The companies – which lobbied extensively for passage of the measure – plan to appeal. Uber tumbled 4.2% in premarket trading, with Lyft sliding 5.1% and DoorDash also losing 2.2%.</p>\n<p>PayPal(PYPL) – PayPal will allow customers in the UK to buy, hold and sell cryptocurrencies beginning this week, its first rollout of cryptocurrency services outside the United States. PayPal added 1% in the premarket.</p>\n<p>Robinhood(HOOD) – The company behind the popular trading app was added to coverage at a handful of investment firms following its late July initial public offering, including Goldman Sachs (neutral rating), Mizuho (buy), JMP Securities (outperform), Barclays (equal weight) and Piper Sandler (neutral). Robinhood added 3.7% in the premarket.</p>\n<p>JD.com(JD) – The Chinese e-commerce company reported better-than-expected profit and revenue for the second quarter while adding a record number of new users.</p>\n<p>Walt Disney Co(DIS)&nbsp; –&nbsp;Walt Disney&nbsp;rose 0.9% after the media company raked in $125 million in online revenue from Marvel superhero film \"Black Widow\".</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","TRIL":"Defiance Trillion Dollar Club Index ETF",".DJI":"道琼斯","PYPL":"PayPal",".IXIC":"NASDAQ Composite","HOOD":"Robinhood","LYFT":"Lyft, Inc.",".SPX":"S&P 500 Index","UBER":"优步","JD":"京东","GM":"通用汽车","BNTX":"BioNTech SE","09618":"京东集团-SW","DIS":"迪士尼","COIN":"Coinbase Global, Inc.","DASH":"DoorDash, Inc.","BA":"波音"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132832038","content_text":"Futures rebound as oil stocks jump; PMI data in focus\n\n\nBitcoin rises above $50,000; crypto stocks rallies\n\nU.S. stock index futures rose on Monday, with oil shares leading the pack, as investors returned to riskier assets after a sharp selloff last week on worries about a slowing pace of U.S. economic growth.\nAt 8:00 a.m. ET, Dow e-minis were up 160 points, or 0.46%, S&P 500 e-minis were up 15.5 points, or 0.35%, and Nasdaq 100 e-minis were up 47.25 points, or 0.31%.\n\nApple Inc, Amazon.com and Tesla Inc were all up between 0.3% and 1% before the opening bell.\nOil majors Chevron Corp, Exxon Mobil, Schlumberger NV and Occidental Petroleum gained between 2% and 3.6% in premarket trading, tracking a 3% jump in crude prices.\nIHS-Markit's flash reading of U.S. business activity, due at 9:45 a.m. ET, is expected to retreat in August to 58.3 from 59.9 in July.\nFocus is now on the Fed's annual economic symposium in Jackson Hole, Wyoming, for more insight on the timeline for the central bank's tapering of its asset purchases. The summit will be held virtually on Aug. 27 for the second straight year.\nStocks making the biggest moves premarket:\nBoeing(BA) – Boeing added 1.4% in the premarket, following news that it planned to invest in a SPAC merger planned later this year by Richard Branson’s satellite launch company Virgin Orbit. Virgin Orbit plans to merge with blank-check companyNextGen Acquisition(XOS), whose shares jumped 6% following the announcement.\nCoinbase(COIN) – Coinbase jumped 3.6% in premarket trading, with the cryptocurrency exchange’s stock benefiting from bitcoin rising to its highest level since early May. Shares of the business analytics company MicroStrategy(MSTR) – which has extensive bitcoin holdings – rallied 3.9%.\nPfizer(PFE),BioNTech(BNTX) – The drug makers are expected to receive full FDA approval for their Covid-19 vaccine as soon as today, according to multiple reports. The vaccine had received emergency use authorization in late 2020. Pfizer added 3.3% in premarket action while BioNTech surged 7.1%.Moderna(MRNA) is also in the process of applying for full FDA approval of its Covid-19 vaccine and its shares rose 2.7%.\nTrillium Therapeutics(TRIL) – Pfizer said it would buy the portion of the cancer therapy specialist that it doesn’t already own in a deal worth $2.26 billion or $18.50 per share in cash. That compares to Trillium’s Friday close of $6.09 per share. Pfizer had invested $25 million in Trillium in September 2020. Trillium shares nearly tripled in premarket trading.\nGeneral Motors(GM) – General Motors expanded the recall of its Chevy Bolt electric car to include newer models, a move that will cost the automaker an additional $1 billion. The recall will address an issue that can increase the risk of battery fires. GM fell 1.5% in the premarket.\nUber(UBER),Lyft(LYFT),DoorDash(DASH) – These stocks are on watch after a California judge ruled the state’s “gig workers” law was unconstitutional. California voters had approved a ballot measure last November allowing those companies to treat workers as independent contractors rather than employees. The companies – which lobbied extensively for passage of the measure – plan to appeal. Uber tumbled 4.2% in premarket trading, with Lyft sliding 5.1% and DoorDash also losing 2.2%.\nPayPal(PYPL) – PayPal will allow customers in the UK to buy, hold and sell cryptocurrencies beginning this week, its first rollout of cryptocurrency services outside the United States. PayPal added 1% in the premarket.\nRobinhood(HOOD) – The company behind the popular trading app was added to coverage at a handful of investment firms following its late July initial public offering, including Goldman Sachs (neutral rating), Mizuho (buy), JMP Securities (outperform), Barclays (equal weight) and Piper Sandler (neutral). Robinhood added 3.7% in the premarket.\nJD.com(JD) – The Chinese e-commerce company reported better-than-expected profit and revenue for the second quarter while adding a record number of new users.\nWalt Disney Co(DIS)  – Walt Disney rose 0.9% after the media company raked in $125 million in online revenue from Marvel superhero film \"Black Widow\".","news_type":1,"symbols_score_info":{"BNTX":0.9,"HOOD":0.9,".SPX":0.9,"COIN":0.9,".IXIC":0.9,".DJI":0.9,"LYFT":0.9,"GM":0.9,"YMmain":0.9,"UBER":0.9,"DASH":0.9,"BA":0.9,"ESmain":0.9,"TRIL":0.9,"09618":0.9,"JD":0.9,"NQmain":0.9,"PYPL":0.9,"PFE":0.9,"DIS":0.9}},"isVote":1,"tweetType":1,"viewCount":983,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816429803,"gmtCreate":1630515201002,"gmtModify":1676530328185,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"should&nbsp; buy sundial&nbsp;","listText":"should&nbsp; buy sundial&nbsp;","text":"should buy sundial","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/816429803","repostId":"2164890060","repostType":4,"repost":{"id":"2164890060","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630508469,"share":"https://ttm.financial/m/news/2164890060?lang=&edition=fundamental","pubTime":"2021-09-01 23:01","market":"us","language":"en","title":"U.S. pot producer Terrascend to buy rival Gage Growth for $545 mln - sources","url":"https://stock-news.laohu8.com/highlight/detail?id=2164890060","media":"Reuters","summary":"Sept 1 (Reuters) - Terrascend will buy Michigan-based rival Gage Growth Corp, backed by prominent ca","content":"<p>Sept 1 (Reuters) - Terrascend will buy Michigan-based rival Gage Growth Corp, backed by prominent cannabis investor Jason Wilde, for around $545 million, the U.S. pot producer said on Wednesday.</p>\n<p>Dealmaking in the U.S. cannabis industry has heated up this year as companies bank on Democrats' promises to reform marijuana laws and potentially legalize the plant at the federal level.</p>\n<p>However, little progress has been made so far and weed stocks have fallen off a cliff in recent months. Gage Growth shares have plunged about 22% up to its last close, since its direct Canadian listing in April.</p>\n<p>Gage Growth, which closed its first day of trading at C$2.89 ($2.29) on April 6, will receive an implied consideration of C$2.66 per share in the merger.</p>\n<p>The combined company will have operations in five U.S. states and Canada, including seven cultivation and processing facilities and 23 operating dispensaries in the two countries, Terrascend said in a statement.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. pot producer Terrascend to buy rival Gage Growth for $545 mln - sources</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. pot producer Terrascend to buy rival Gage Growth for $545 mln - sources\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-01 23:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sept 1 (Reuters) - Terrascend will buy Michigan-based rival Gage Growth Corp, backed by prominent cannabis investor Jason Wilde, for around $545 million, the U.S. pot producer said on Wednesday.</p>\n<p>Dealmaking in the U.S. cannabis industry has heated up this year as companies bank on Democrats' promises to reform marijuana laws and potentially legalize the plant at the federal level.</p>\n<p>However, little progress has been made so far and weed stocks have fallen off a cliff in recent months. Gage Growth shares have plunged about 22% up to its last close, since its direct Canadian listing in April.</p>\n<p>Gage Growth, which closed its first day of trading at C$2.89 ($2.29) on April 6, will receive an implied consideration of C$2.66 per share in the merger.</p>\n<p>The combined company will have operations in five U.S. states and Canada, including seven cultivation and processing facilities and 23 operating dispensaries in the two countries, Terrascend said in a statement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2164890060","content_text":"Sept 1 (Reuters) - Terrascend will buy Michigan-based rival Gage Growth Corp, backed by prominent cannabis investor Jason Wilde, for around $545 million, the U.S. pot producer said on Wednesday.\nDealmaking in the U.S. cannabis industry has heated up this year as companies bank on Democrats' promises to reform marijuana laws and potentially legalize the plant at the federal level.\nHowever, little progress has been made so far and weed stocks have fallen off a cliff in recent months. Gage Growth shares have plunged about 22% up to its last close, since its direct Canadian listing in April.\nGage Growth, which closed its first day of trading at C$2.89 ($2.29) on April 6, will receive an implied consideration of C$2.66 per share in the merger.\nThe combined company will have operations in five U.S. states and Canada, including seven cultivation and processing facilities and 23 operating dispensaries in the two countries, Terrascend said in a statement.","news_type":1,"symbols_score_info":{"TRSSF":0.9}},"isVote":1,"tweetType":1,"viewCount":1426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":476427118252368,"gmtCreate":1757342619882,"gmtModify":1757342623432,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/RR\">$Richtech Robotics(RR)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/RR\">$Richtech Robotics(RR)$ </a>&nbsp;","text":"$Richtech Robotics(RR)$","images":[{"img":"https://community-static.tradeup.com/news/e085bae5033c62bb0e9b3b015c870900","width":"1080","height":"2748"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/476427118252368","isVote":1,"tweetType":1,"viewCount":747,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":818232208,"gmtCreate":1630412068404,"gmtModify":1676530295824,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>this month need it reach$1 pls......God Allah Buddha Brahman help help.....","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>this month need it reach$1 pls......God Allah Buddha Brahman help help.....","text":"$Sundial Growers Inc.(SNDL)$this month need it reach$1 pls......God Allah Buddha Brahman help help.....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818232208","isVote":1,"tweetType":1,"viewCount":1606,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":475725486551304,"gmtCreate":1757171321922,"gmtModify":1757171323446,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","text":"$NVIDIA(NVDA)$","images":[{"img":"https://community-static.tradeup.com/news/faa5660385d84fd16372b402d61264fb","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/475725486551304","isVote":1,"tweetType":1,"viewCount":528,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":475725429145960,"gmtCreate":1757171198818,"gmtModify":1757171204976,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","text":"$NVIDIA(NVDA)$","images":[{"img":"https://community-static.tradeup.com/news/eaa06eeeab6aa14d0c826e1d82eac699","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/475725429145960","isVote":1,"tweetType":1,"viewCount":503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":468266240549080,"gmtCreate":1755347562860,"gmtModify":1755347565870,"author":{"id":"4091708143350050","authorId":"4091708143350050","name":"Likelike","avatar":"https://static.tigerbbs.com/0c535dfd23243cbd1cba5aae16cf970c","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4091708143350050","idStr":"4091708143350050"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA(NVDA)$ </a>&nbsp;","text":"$NVIDIA(NVDA)$","images":[{"img":"https://community-static.tradeup.com/news/46fcbcaa2a0d9930fb53d9a14b2d63e1","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/468266240549080","isVote":1,"tweetType":1,"viewCount":743,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}